Clinical Trial Update: Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating olverembatinib as monotherapy for newly diagnosed chronic phase chronic myeloid leukemia; the study is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Olverembatinib (Olverembatinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Myeloid Leukemia | Phase 2 | Status: RECRUITING